Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer

Biomaterials

Volumn 61, Issue , 2015, Pages 115-125

  Kim, Dong Hee ^a   Seo, Young Kyu ^a   Thambi, Thavasyappan ^a   Moon, Gyeong Joon ^b   Son, Jung Pyo ^a   Li, Guangri ^a   Park, Jae Hyung ^a   Lee, Jung Hee ^a,b,c   Kim, Hyeon Ho ^a,b   Lee, Doo Sung ^a   Bang, Oh Young ^a,b,c  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Angiogenesis; Ischemic stroke; Neurogenesis; PH sensitive; Polymeric micelle; SDF 1

Indexed keywords

AMINES; CONTROLLED DRUG DELIVERY; CYTOLOGY; FUNCTIONAL POLYMERS; INFRARED DEVICES; MICELLES; MOLECULES; PH EFFECTS; PH SENSORS; PROTEINS; RATS; STEM CELLS;

ANGIOGENESIS; ISCHEMIC STROKES; NEUROGENESIS; PH SENSITIVE; POLYMERIC MICELLE;

TARGETED DRUG DELIVERY;

COPOLYMER; STROMAL CELL DERIVED FACTOR 1ALPHA; DELAYED RELEASE FORMULATION; ION; NANOCAPSULE; POLYMER; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BRAIN ISCHEMIA; CELL HOMING; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTERNAL CAROTID ARTERY; FLUORESCENCE IMAGING; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY; IONIZATION; MALE; MICELLE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PH; PRIORITY JOURNAL; RAT; RIGHT COMMON CAROTID ARTERY; STEM CELL; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG EFFECTS; PATHOLOGY; SPRAGUE DAWLEY RAT; SYNTHESIS; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT;

RATTUS;

ANIMALS; BRAIN ISCHEMIA; CELLULAR MICROENVIRONMENT; CHEMOKINE CXCL12; DELAYED-ACTION PREPARATIONS; DIFFUSION; HYDROGEN-ION CONCENTRATION; IONS; MALE; NANOCAPSULES; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 84939123462     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.05.025     Document Type: Article

References (47)

1. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008, 55:363-389.
2. Chang W.H., Bang O.Y., Shin Y.-I., Lee A., Pascual-Leone A., Kim Y.-H. BDNF polymorphism and differential rTMS effects on motor recovery of stroke patients. Brain Stimul. 2014, 7:553-558.
3. Lee J.S., Hong J.M., Moon G.J., Lee P.H., Ahn Y.H., Bang O.Y. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010, 28:1099-1106.
4. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
5. Huang X., Zhang F., Wang Y., Sun X., Choi K.Y., Liu D., et al. Design considerations of iron-based nanoclusters for noninvasive tracking of mesenchymal stem cell homing. ACS Nano 2014, 8:4403-4414.
6. Shyu W.-C., Lin S.-Z., Yen P.-S., Su C.-Y., Chen D.-C., Wang H.-J., et al. Stromal cell-derived factor-1α promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J. Pharmacol. Exp. Ther. 2008, 324:834-849.
7. Zhang Y., Pardridge W.M. Neuroprotection in transient focal brain ischemia After delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke 2001, 32:1378-1384.
8. Kim B.-S., Park S.W., Hammond P.T. Hydrogen-bonding layer-by-layer-assembled biodegradable polymeric micelles as drug delivery vehicles from surfaces. ACS Nano 2008, 2:386-392.
9. Wu W., Shen J., Gai Z., Hong K., Banerjee P., Zhou S. Multi-functional core-shell hybrid nanogels for pH-dependent magnetic manipulation, fluorescent pH-sensing, and drug delivery. Biomaterials 2011, 32:9876-9887.
10. Thambi T., Park J.H. Recent advances in shell-sheddable nanoparticles for cancer therapy. J. Biomed. Nanotechnol. 2014, 10:1841-1862.
11. Thambi T., You D.G., Han H.S., Deepagan V.G., Jeon S.M., Suh Y.D., et al. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery. Adv. Healthc. Mater. 2014, 3:1829-1838.
12. Sivasubramanian M., Thambi T., Park J.H. Mineralized cyclodextrin nanoparticles for sustained protein delivery. Carbohydr. Polym. 2013, 97:643-649.
13. Cohen S., Coué G., Beno D., Korenstein R., Engbersen J.F.J. Bioreducible poly(amidoamine)s as carriers for intracellular protein delivery to intestinal cells. Biomaterials 2012, 33:614-623.
14. Huynh C.T., Nguyen M.K., Lee D.S. Dually cationic and anionic pH/temperature-sensitive injectable hydrogels and potential application as a protein carrier. Chem. Commun. 2012, 48:10951-10953.
15. Gao G.H., Park M.J., Li Y., Im G.H., Kim J.-H., Kim H.N., et al. The use of pH-sensitive positively charged polymeric micelles for protein delivery. Biomaterials 2012, 33:9157-9164.
16. Baumann L., Prokoph S., Gabriel C., Freudenberg U., Werner C., Beck-Sickinger A.G. A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro. J. Controlled Release 2012, 162:68-75.
17. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.-Y., Tang L. The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31:3997-4008.
18. Prokoph S., Chavakis E., Levental K.R., Zieris A., Freudenberg U., Dimmeler S., et al. Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells. Biomaterials 2012, 33:4792-4800.
19. Bladergroen B.A., Siebum B., Siebers-Vermeulen K.G.C., Van Kuppevelt T.H., Poot A.A., Feijen J., et al. In vivo recruitment of hematopoietic cells using stromal cell-derived factor 1 alpha-loaded heparinized three-dimensional collagen scaffolds. Tissue Eng. A 2008, 15:1591-1599.
20. Segers V.F.M., Tokunou T., Higgins L.J., MacGillivray C., Gannon J., Lee R.T. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007, 116:1683-1692.
21. Henderson P.W., Singh S.P., Krijgh D.D., Yamamoto M., Rafii D.C., Sung J.J., et al. Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo. Wound Repair Regen. 2011, 19:420-425.
22. Takano K., Tatlisumak T., Bergmann A.G., Gibson Iii D.G., Fisher M. Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats. J. Neurol. Sci. 1997, 153:8-11.
23. Koo A.N., Min K.H., Lee H.J., Lee S.-U., Kim K., Chan Kwon I., et al. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Biomaterials 2012, 33:1489-1499.
24. Vazquez E., Corchero J., Villaverde A. Post-production protein stability: trouble beyond the cell factory. Microb. Cell Fact. 2011, 10:60.
25. Ehrenreich H., Weissenborn K., Prange H., Schneider D., Weimar C., Wartenberg K., et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009, 40:e647-e656.
26. Verma I.M., Somia N. Gene therapy - promises, problems and prospects. Nature 1997, 389:239-242.
27. Faralli A., Bigoni M., Mauro A., Rossi F., Carulli D. Noninvasive strategies to promote functional recovery after stroke. Neural Plast. 2013, 2013:16.
28. Morimoto T., Morimoto T., Yasuhara T., Yasuhara T., Kameda M., Kameda M., et al. Striatal stimulation nurtures endogenous neurogenesis and angiogenesis in chronic-phase ischemic stroke rats. Cell Transplant. 2011, 20:1049-1064.
29. Bang O.Y., Lee J.S., Lee P.H., Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005, 57:874-882.
30. Honmou O., Houkin K., Matsunaga T., Niitsu Y., Ishiai S., Onodera R., et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011, 134:1790-1807.
31. Chen X., Li Y., Wang L., Katakowski M., Zhang L., Chen J., et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002, 22:275-279.
32. Paljärvi L., Rehncrona S., Söderfeldt B., Olsson Y., Kalimo H. Brain lactic acidosis and ischemic cell damage: quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol. 1983, 60:232-240.
33. Pignataro G., Simon R.P., Xiong Z.-G. Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia. Brain 2007, 130:151-158.
34. Hill W.D.H.D., Martin-Studdard A., Carothers J.J., Zheng J., Hale D., Maeda M., Fagan S.C., Carroll J.E., Conway S.J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 2004, 63:84-96.
35. Schönemeier B., Schulz S., Hoellt V., Stumm R. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J. Neuroimmunol. 2008, 198:39-45.
36. Miller J., Bartley J., Wimborne H., Walker A., Hess D., Hill W., et al. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci. 2005, 6:1-11.
37. Chopp M., Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurology 2002, 1:92-100.
38. Körbling M., Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept?. New. Engl. J. Med. 2003, 349:570-582.
39. Cesari F., Nencini P., Nesi M., Caporale R., Giusti B., Abbate R., et al. Bone marrow-derived progenitor cells in the early phase of ischemic stroke: relation with stroke severity and discharge outcome. J. Cereb. Blood Flow Metab. 2009, 29:1983-1990.
40. Jung K.-H., Chu K., Lee S.-T., Song E.-C., Sinn D.-I., Kim J.-M., et al. Identification of neuronal outgrowth cells from peripheral blood of stroke patients. Ann. Neurol. 2008, 63:312-322.
41. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 2003, 92:692-699.
42. Cui X., Chen J., Zacharek A., Roberts C., Yang Y., Chopp M. Nitric oxide donor up-regulation of SDF1/CXCR4 and Ang1/Tie2 promotes neuroblast cell migration after stroke. J. Neurosci. Res. 2009, 87:86-95.
43. Weber R., Ramos-Cabrer P., Hoehn M. Present status of magnetic resonance imaging and spectroscopy in animal stroke models. J. Cereb. Blood Flow Metab. 2005, 26:591-604.
44. Katayama Y., Fujii K., Ito E., Sakakihara S., Sonoda T., Murata M., et al. Intracellular signal-responsive artificial gene regulation for novel gene delivery. Biomacromolecules 2002, 3:905-909.
45. Zhao M., Biswas A., Hu B., Joo K.-I., Wang P., Gu Z., et al. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials 2011, 32:5223-5230.
46. Thambi T., Yoon H.Y., Kim K., Kwon I.C., Yoo C.K., Park J.H. Bioreducible block copolymers based on poly (ethylene glycol) and poly (γ-benzyl L-glutamate) for intracellular delivery of camptothecin. Bioconjug. Chem. 2011, 22:1924-1931.
47. Thambi T., Deepagan V.G., Yoon H.Y., Han H.S., Kim S.-H., Son S., et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials 2014, 35:1735-1743.